Lucira Health, Inc. (LHDX)
LHDXPrice: $0.45
Fair Value: 🔒
🔒score
Lucira Health, Inc., a medical technology company, focuses on the development and commercialization of infectious disease test kits. It develops a testing platform that produces molecular testing services. The company offers LUCIRA COVID-19 All-In-One Test Kit, a COVID-19 test kit; and develops infl... more
Lucira Health, Inc., a medical technology company, focuses on the development and commercialization ... more
Description
Shares
| Market Cap | $18.36M | Exchange | NASDAQ |
| Sector | Healthcare | Industry | Medical - Devices |
| Country | US | CEO | Erik T. Engelson |
| IPO Date | 2021-02-04 | CAGR | — |
| Employees | 221 | Website | www.lucirahealth.com |
| Div. Yield | — | Payout Ratio | — |
| Buy Back Yield | -3.44% | Total Yield | -3.44% |
LHDX chart loading...
Fundamentals
Technicals
| Enterprise Value | $50.95M | P/E Ratio | -0.14 |
| Forward P/E | — | PEG Ratio | — |
| P/S Ratio | 0.2 | P/B Ratio | 0.08 |
| P/CF Ratio | -0.16 | P/FCF Ratio | -0.16 |
| EPS | $-3.14 | EPS Growth 1Y | — |
| EPS Growth 3Y | — | EPS Growth 5Y | — |
| Revenue Growth 1Y | 558.8% | Gross Margin | 0.11% |
| Operating Margin | -0.69% | Profit Margin | -0.7% |
| ROE | -1.02% | ROA | -0.27% |
| ROCE | -0.34% | Current Ratio | 4.1 |
| Quick Ratio | 3.09 | Cash Ratio | 2.11 |
| Debt/Equity | 0.01 | Interest Coverage | -21513.33 |
| Altman Z Score | -2.98 | Piotroski Score | 2 |